The present invention relates to compound of the following structure
for use as an inhibitor of TrkA, as well as compositions including this compound, and methods of using this compound for the treatment of pain including post-surgical pain, rheumatoid arthritis pain, neuropathic pain and osteoarthritis pain.
PYRROLO [2, 3 -D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF TROPOMYOSIN- RELATED KINASES
申请人:Pfizer Limited
公开号:EP2694509A1
公开(公告)日:2014-02-12
PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF TROPOMYOSIN-RELATED KINASES
申请人:Pfizer Limited
公开号:EP2694509B1
公开(公告)日:2016-05-18
US8846698B2
申请人:——
公开号:US8846698B2
公开(公告)日:2014-09-30
[EN] PYRROLO [2, 3 -D] PYRIMIDINE DERIVATIVES AS INHIBITORS OF TROPOMYOSIN- RELATED KINASES<br/>[FR] DÉRIVÉS DE PYRROLO-[2,3-D]PYRIMIDINE EN TANT QU'INHIBITEURS DES KINASES ASSOCIÉES À LA TROPOMYOSINE
申请人:PFIZER LTD
公开号:WO2012137089A1
公开(公告)日:2012-10-11
The present invention relates to compounds of Formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine, in particular as Trk antagonists.